IVF hartmann Holding AG (XSWX:VBSN) ROCE %: 15.50% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:VBSN IVF hartmann Holding AG XSWX:VBSN
74 GF Score
Price CHF130.50
GF Value CHF143.29
Valuation Fairly Valued
View Full Analysis

What is IVF hartmann Holding AG ROCE %?

IVF hartmann Holding AG XSWX:VBSN +1.92% 74 ROCE % is 15.50% as of Dec. 2025. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.29 (Fairly Valued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IVF hartmann Holding AG's annualized ROCE % for the quarter that ended in Dec. 2025 was 15.50%.

IVF hartmann Holding AG  (XSWX:VBSN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IVF hartmann Holding AG ROCE % Related Terms

IVF hartmann Holding AG ROCE % Historical Data

* Premium members only.

The historical data trend for IVF hartmann Holding AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IVF hartmann Holding AG ROCE % Chart

IVF hartmann Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.40 9.34 11.82 15.50 13.58

IVF hartmann Holding AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.46 13.88 18.19 12.39 15.50
XSWX:VBSN
74GF Score
IVF hartmann Holding AG XSWX:VBSN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IVF hartmann Holding AG ROCE % Calculation

IVF hartmann Holding AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=21.435/( ( (189.014 - 32.877) + (196.064 - 36.559) )/ 2 )
=21.435/( (156.137+159.505)/ 2 )
=21.435/157.821
=13.58 %

IVF hartmann Holding AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=23.936/( ( (180.923 - 31.479) + (196.064 - 36.559) )/ 2 )
=23.936/( ( 149.444 + 159.505 )/ 2 )
=23.936/154.4745
=15.50 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.50% mean?
IVF hartmann Holding AG (XSWX:VBSN) has a ROCE % of 15.50% as of Dec. 2025.
Is IVF hartmann Holding AG's ROCE % too high?
IVF hartmann Holding AG's current ROCE % is 15.50%. The Medical Devices & Instruments industry median ROCE % is 2.26. IVF hartmann Holding AG's value of 15.50% is 585.8% above this industry median. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's ROCE % compare to ISRG and BDX?
IVF hartmann Holding AG's ROCE % of 15.50% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.26. IVF hartmann Holding AG's value of 15.50% is 585.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.26, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current ROCE % of 15.50% is 585.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current ROCE % is 15.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF143.29, compared to a current price of CHF130.50 — trading 8.9% below its estimated fair value. The current ROCE % is 15.50% and 585.8% above the Medical Devices & Instruments industry median of 2.26. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current ROCE % is 15.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?

Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued. The current stock price of CHF130.50 is trading 8.9% below its estimated GF Value™ of CHF143.29. GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.

Key valuation signals for XSWX:VBSN:

  • ROCE %: 15.50%
  • GF Value™: CHF143.29 vs. price of CHF130.50 (8.9% below fair value)
  • GF Score™: 74/100
  • Industry Position: 585.8% above the Medical Devices & Instruments median

No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IVF hartmann Holding AG Business Description

Other Exchanges VBSNz:UK0QQM:UK
Address Victor von Bruns Street 28, PO Box 634, Neuhausen, CHE, 8212
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score

Get the complete analysis for XSWX:VBSN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF130.50
Price
CHF143.29
GF Value